VBIO CIK: 1787740

Valion Bio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY24
millions USD
FY21:
−0.04
FY22:
0.30
FY23:
0.29
FY24:
0.00
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−5.63
FY22:
−10.1
FY23:
−8.25
FY24:
−5.66
FY25:
−7.90
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−7.87
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−10.1
FY23:
−8.24
FY24:
–
FY25:
−7.99
(positive)
Change from FY21 to FY25
millions USD
FY21:
−8.49
FY22:
−10.1
FY23:
−8.24
FY24:
−5.66
FY25:
−8.88

All amounts in millions USD Data sources:SEC EDGARTwelve Data